OPPENHEIMER ASSET MANAGEMENT INC. - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 52 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2022$102,000
+2.0%
78,000
-2.5%
0.00%0.0%
Q4 2021$100,000
-11.5%
80,000
-5.9%
0.00%
-50.0%
Q3 2021$113,000
-4.2%
85,000
-3.4%
0.00%0.0%
Q2 2021$118,000
+25.5%
88,000
+25.7%
0.00%
+100.0%
Q1 2021$94,000
-1.1%
70,000
+1.4%
0.00%
-50.0%
Q4 2020$95,000
-4.0%
69,000
-4.2%
0.00%0.0%
Q3 2020$99,000
-16.1%
72,000
+1.4%
0.00%0.0%
Q2 2020$118,000
+29.7%
71,0000.0%0.00%0.0%
Q1 2020$91,000
-16.5%
71,0000.0%0.00%0.0%
Q4 2019$109,000
+5.8%
71,000
-5.3%
0.00%0.0%
Q3 2019$103,000
+5.1%
75,0000.0%0.00%0.0%
Q2 2019$98,000
+3.2%
75,000
+7.1%
0.00%0.0%
Q1 2019$95,000
+31.9%
70,000
+16.7%
0.00%0.0%
Q4 2018$72,000
-43.8%
60,000
-20.0%
0.00%
-33.3%
Q3 2018$128,000
+21.9%
75,000
+2.7%
0.00%0.0%
Q2 2018$105,00073,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q1 2021
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 45,447,000$60,497,0001.31%
SHENKMAN CAPITAL MANAGEMENT INC 4,366,000$5,924,0000.54%
Aequim Alternative Investments LP 7,609,000$10,088,0000.43%
MACKAY SHIELDS LLC 27,806,000$37,405,0000.35%
Weiss Asset Management LP 10,000,000$13,290,0000.33%
WOLVERINE ASSET MANAGEMENT LLC 13,230,000$17,541,0000.13%
Polar Asset Management Partners Inc. 7,500,000$9,942,0000.10%
LORD, ABBETT & CO. LLC 22,141,000$29,732,0000.07%
Calamos Advisors LLC 7,500,000$9,967,0000.05%
D. E. Shaw & Co., Inc. 39,270,000$52,046,0000.04%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders